Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.43 GBX | +2.30% |
|
-8.60% | +37.35% |
05-01 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
05-01 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
76.7M | - | - | - | - | - | |
121B | ||||||
114B | ||||||
23.61B | - | |||||
20.43B | - | |||||
16.55B |
- Stock Market
- Equities
- POLB Stock
- Charts Poolbeg Pharma PLC
- Sector Chart